FCX-007 / Precigen, Paragon Biosci 
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
FCX-007 / Precigen, Paragon Biosci
DEFI-RDEB, NCT04213261: A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Active, not recruiting
3
6
US
FCX-007 (dabocemagene autoficel; see below for FCX-007 description)
Castle Creek Biosciences, LLC.
Recessive Dystrophic Epidermolysis Bullosa
01/23
07/37
RDEB, NCT02810951: A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Terminated
1/2
6
US
FCX-007, Genetically-Modified Autologous Human Dermal Fibroblasts
Castle Creek Biosciences, LLC.
Epidermolysis Bullosa Dystrophica, Recessive
09/20
04/22

Download Options